First Tracks Biotherapeutics Inc
TRAX | NASDAQ
$45.08
-$0.15 (-0.32%)
At close: Oct 30, 2026, 4:00 PM ET
$45.50
+$0.42 (+0.93%)
Pre-market:
Nov 2, 2026, 7:00 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|
Net Income | -83.86M | -50.48M | -47.2M |
Depreciation & Amortization | 332K | 125K | 606K |
Stock-Based Compensation | 11.5M | 11.5M | 7.75M |
Other Working Capital | -10.3M | 2.16M | -905K |
Other Non-Cash Items | 8.46M | -8K | -1.67M |
Deferred Income Tax | n/a | n/a | n/a |
Change in Working Capital | -913K | 6.3M | -4.5M |
Operating Cash Flow | -64.48M | -32.56M | -45.01M |
Capital Expenditures | -42K | -17K | -35K |
Cash Acquisitions | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -122.55M |
Sales Maturities Of Investments | 35M | 35M | 137.43M |
Other Investing Acitivies | n/a | n/a | n/a |
Investing Cash Flow | 34.96M | 34.98M | 14.85M |
Debt Repayment | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a |
Other Financial Acitivies | -319.35M | 7.85M | 5.72M |
Financial Cash Flow | -40.66M | 7.85M | 5.72M |
Net Cash Flow | -70.18M | 10.27M | -24.44M |
Free Cash Flow | -64.52M | -32.58M | -45.04M |
Adj. Free Cash Flow | -76.02M | -44.08M | -52.79M |
Maintenance CapEx | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a |
Owner Earnings | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TRAX